Palavras-chave
Autismo
Benefícios
Como Citar
Resumo
RESUMO
Objetivo: alertar sobre possíveis benefícios que a terapia com cannabis pode exercer sobre pacientes com TEA. Método: Foi realizada uma busca no National Library of Medicine (PubMed) e a Biblioteca Virtual em Saúde (BVS) para constituir o compilado bibliográfico dessa revisão de literatura. Os descritores utilizados foram ‘‘benefits’’, ‘‘cannabis’’ e ‘‘autism’’. Os critérios de inclusão foram delimitação de data dos artigos entre 2017 e 2025 e textos em inglês, espanhol ou português. Foram excluídos os artigos que não tinham definição de embasamento teórico e temático alinhado aos objetivos do estudo, artigos duplicados ou que não relacionavam com o objetivo do estudo. Resultados: Dentre os 25 artigos selecionados neste estudo, 11 concluíram existir algum tipo de benefício no uso dos componentes da cannabis no tratamento de pacientes com transtorno do espectro autista e outras desordens neuropsiquiátricas. Onze (11) concluíram á necessidade de mais estudos sobre o tema proposto, para serem avaliado se houve benefícios, e 3 concluíram que o tratamento não possui benefícios ou que possui elevados riscos para saúde dos pacientes. Considerações finais: A análise do tratamento à base de cannabis em pacientes autistas se mostrou relevante, trazendo benefícios, se for administrado de forma correta, e de forma individualizada
Palavras-chave: Benefícios, Cannabis, Autismo.
Referências
Agarwal R, Burke SL, Maddux M. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC Psychiatry. 2019 Oct 29;19(1).
Alves P, et al. Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol. Pharmacological Research. 2020 Jul; 157:104822.
Al-Soleiti M, et al; Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2021 Sep 9;
Babayeva M, et al. Autism and associated disorders: cannabis as a potential therapy. Frontiers in Bioscience-Elite. 2022 Jan 13;14(1):1.
Chayasirisobhon S. Cannabis and Neuropsychiatric Disorders: An Updated Review. Acta Neurologica Taiwanica [Internet]. 2019 Jun 15;28(2):27–39
Cairns EA, et al. Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing. Frontiers in Pharmacology. 2023 Jun 6;14.
Duvall SW, et al. Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders. Pediatrics [Internet]. 2019 Feb 1;143(2)
Fernández-Ruiz J, et al. Possible therapeutic applications of cannabis in the neuropsychopharmacology field. European Neuropsychopharmacology. 2020 Jul; 36:217–34.
Fletcher S, et al. Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review. Child: Care, Health, and Development. 2021 Aug 31;48(1):33–44.
Hill MN, et al. The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses. Psychological Medicine [Internet]. 2023 Sep 6 [cited 2023 Oct 10];1–19.
Hacohen M, et al. Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study. Translational Psychiatry [Internet]. 2022 Sep 9;12(1):375.
Holdman R, et al. Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications. Cannabis and Cannabinoid Research. 2021 Aug 24.
Inglet S, et al. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature. The Annals of Pharmacotherapy [Internet]. 2020 Nov 1;54(11):1109–43.
Jugl S, et al. A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Medical Cannabis and Cannabinoids. 2021 Feb 25;4(1):21–42.
Mostafavi M, Gaitanis J. Autism Spectrum Disorder and Medical Cannabis: Review & Clinical Experience. Seminars in Pediatric Neurology. 2020 Jul;100833.
Montagner PSS, et al. Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits. Frontiers in Psychiatry [Internet]. 2023
Mansell H, et al. Medical cannabis in schools: The experiences of caregivers. Paediatrics & Child Health [Internet]. 2023 May
Oliveira MCR de et al. Pacientes neuropsiquiátricos e os benefícios do tratamento com fitocanabinóides. Arq ciências saúde UNIPAR [Internet]. 2023;4537–59.
Ponton JA, et al. A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report. Journal of Medical Case Reports. 2020 Sep 22;14(1).
Parrella NF, et al. A systematic review of cannabidiol trials in neurodevelopmental disorders. Pharmacology Biochemistry and Behavior [Internet]. 2023 Sep 1 [cited 2023 Sep 10]; 230:173607.
Pretzsch CM, et al. The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD). J Psychopharmacol [Internet].
Siani-Rose M, et al. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder. Cannabis and Cannabinoid Research. 2021 Dec 6.
Solimini R, et al. Neurological Disorders in Medical Use of Cannabis: An Update. CNS & Neurological Disorders - Drug Targets. 2017 Aug 9;16(5).
Staben J, et al. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder. Frontiers in Neuroscience [Internet]. 2023 [cited 2023 Oct 10]; 17:118573
Virgilio S, et al. Cannabinoides en pacientes con trastornos del espectro autista. pesquisabvsaludorg [Internet]. 2017
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Fernando Fernandes Figueira, Carlos Alberto Bhering
